Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan van Lunzen

Showing results (11-20 of 112) with videos related to

Pageof 12
Sort By:
The Journal of Clinical Investigation|May 5, 2010
IL-10 induces aberrant deletion of dendritic cells by natural killer cells in the context of HIV infectionGalit Alter, Daniel Kavanagh, Suzannah Rihn, et al.
Journal of Immunological Methods|December 3, 2014
CMV specific cytokine release assay in whole blood is optimized by combining synthetic CMV peptides and toll like receptor agonistsWerner Dammermann, David Bochmann, Frank Bentzien, et al.
The Journal of Infectious Diseases|May 30, 2009
Cumulative HIV viremia during highly active antiretroviral therapy is a strong predictor of AIDS-related lymphomaAlexander Zoufaly, Hans-Jürgen Stellbrink, Matthias An der Heiden, et al.
British Journal of Haematology|January 17, 2007
Adoptive transfer of syngeneic T cells in HIV-1 discordant twins indicates rapid regulation of T-cell homeostasisChristian Hoffmann, Hans-Juergen Stellbrink, Thomas Dielschneider, et al.
European Journal of Immunology|June 2, 2011
Early viral replication in lymph nodes provides HIV with a means by which to escape NK-cell-mediated controlRutger Luteijn, Gaia Sciaranghella, Jan van Lunzen, et al.
The Patient|August 20, 2015
Patient-Reported Symptoms over 48 Weeks in a Randomized, Open-Label, Phase 3b Non-inferiority Trial of Adults with HIV Switching to Coformulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir DF Versus Continuation of Ritonavir-Boosted Protease Inhibitor with Emtricitabine and Tenofovir DFJoseph Gathe, Jose R Arribas, Jan Van Lunzen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 8, 2009
Sustained virological response after early antiviral treatment of acute hepatitis C virus and HIV coinfectionJulian Schulze Zur Wiesch, Dorothea Pieper, Ingrid Stahmer, et al.
Infection|February 26, 2016
High proportion of HIV late presenters at an academic tertiary care center in northern Germany confirms the results of several cohorts in Germany: time to put better HIV screening efforts on the national agenda?Guido Schäfer, Benno Kreuels, Stefan Schmiedel, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 21, 2008
Relevance of the organic cation transporters 1 and 2 for antiretroviral drug therapy in human immunodeficiency virus infectionNorma Jung, Clara Lehmann, Andrea Rubbert, et al.
Archiv Der Pharmazie|January 4, 2016
Linker-Region Modified Derivatives of the Deoxyhypusine Synthase Inhibitor CNI-1493 Suppress HIV-1 ReplicationMarcus Schröder, Adrian Kolodzik, Björn Windshügel, et al.
Pageof 12

Showing results (11-20 of 112) with videos related to

Sort By:
Pageof 12
The Journal of Clinical Investigation|May 5, 2010
IL-10 induces aberrant deletion of dendritic cells by natural killer cells in the context of HIV infectionGalit Alter, Daniel Kavanagh, Suzannah Rihn, et al.
Journal of Immunological Methods|December 3, 2014
CMV specific cytokine release assay in whole blood is optimized by combining synthetic CMV peptides and toll like receptor agonistsWerner Dammermann, David Bochmann, Frank Bentzien, et al.
The Journal of Infectious Diseases|May 30, 2009
Cumulative HIV viremia during highly active antiretroviral therapy is a strong predictor of AIDS-related lymphomaAlexander Zoufaly, Hans-Jürgen Stellbrink, Matthias An der Heiden, et al.
British Journal of Haematology|January 17, 2007
Adoptive transfer of syngeneic T cells in HIV-1 discordant twins indicates rapid regulation of T-cell homeostasisChristian Hoffmann, Hans-Juergen Stellbrink, Thomas Dielschneider, et al.
European Journal of Immunology|June 2, 2011
Early viral replication in lymph nodes provides HIV with a means by which to escape NK-cell-mediated controlRutger Luteijn, Gaia Sciaranghella, Jan van Lunzen, et al.
The Patient|August 20, 2015
Patient-Reported Symptoms over 48 Weeks in a Randomized, Open-Label, Phase 3b Non-inferiority Trial of Adults with HIV Switching to Coformulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir DF Versus Continuation of Ritonavir-Boosted Protease Inhibitor with Emtricitabine and Tenofovir DFJoseph Gathe, Jose R Arribas, Jan Van Lunzen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 8, 2009
Sustained virological response after early antiviral treatment of acute hepatitis C virus and HIV coinfectionJulian Schulze Zur Wiesch, Dorothea Pieper, Ingrid Stahmer, et al.
Infection|February 26, 2016
High proportion of HIV late presenters at an academic tertiary care center in northern Germany confirms the results of several cohorts in Germany: time to put better HIV screening efforts on the national agenda?Guido Schäfer, Benno Kreuels, Stefan Schmiedel, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 21, 2008
Relevance of the organic cation transporters 1 and 2 for antiretroviral drug therapy in human immunodeficiency virus infectionNorma Jung, Clara Lehmann, Andrea Rubbert, et al.
Archiv Der Pharmazie|January 4, 2016
Linker-Region Modified Derivatives of the Deoxyhypusine Synthase Inhibitor CNI-1493 Suppress HIV-1 ReplicationMarcus Schröder, Adrian Kolodzik, Björn Windshügel, et al.
Pageof 12